Current Status of Simultaneous Liver-Kidney Transplantation in the United States

Erik L Lum; Andrés Cárdenas; Paul Martin; Suphamai Bunnapradist

doi:10.1002/lt.25444

Current Status of Simultaneous Liver-Kidney Transplantation in the United States

Liver Transpl. 2019 May;25(5):797-806. doi: 10.1002/lt.25444. Epub 2019 Apr 3.

Authors

Erik L Lum¹, Andrés Cárdenas², Paul Martin³, Suphamai Bunnapradist¹

Affiliations

¹ Division of Nephrology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA.
² Institute of Digestive Diseases and Metabolism, Hospital Clinic, University of Barcelona, Barcelona, Spain.
³ Division of Gastroenterology and Hepatology, Miller School of Medicine, University of Miami, Miami, FL.

PMID: 30861294
DOI: 10.1002/lt.25444

Abstract

On August 10, 2017, a formal policy was enacted in the United States that defined listing criteria for simultaneous liver-kidney transplantation and priority for patients who received a liver transplantation (LT) and subsequently developed significant kidney disease after LT. This article reviews and summarizes the rationale for such policies, the policies themselves, and the potential impact on LT candidates.

Publication types

Review

MeSH terms

End Stage Liver Disease / complications
End Stage Liver Disease / mortality
End Stage Liver Disease / surgery*
Health Care Rationing / standards
Health Care Rationing / statistics & numerical data
Healthcare Disparities
Humans
Kidney Transplantation / methods
Kidney Transplantation / standards
Kidney Transplantation / statistics & numerical data*
Liver Transplantation / adverse effects
Liver Transplantation / methods
Liver Transplantation / standards
Liver Transplantation / statistics & numerical data*
Patient Selection*
Policy
Registries
Renal Insufficiency / etiology
Renal Insufficiency / surgery*
Risk Factors
Time Factors
Tissue and Organ Procurement / standards
Tissue and Organ Procurement / statistics & numerical data
United States / epidemiology
Waiting Lists